Groups Similar Look up By Text Browse About

Similar articles
Article Id Title Prob Score Similar Compare
220921 ARSTECHNICA 2021-11-19:
Adults nationwide eligible for boosters this weekend as CDC gives sign-off
1.000 Find similar Compare side-by-side
220648 ARSTECHNICA 2021-11-19:
FDA authorizes Pfizer and Moderna COVID boosters for all adults
0.948 0.678 Find similar Compare side-by-side
220683 ARSTECHNICA 2021-11-17:
Boosters for all is critical, not a luxury, Fauci says as FDA decision nears
0.172 0.635 Find similar Compare side-by-side
220739 THEVERGE 2021-11-19:
FDA clears Pfizer and Moderna COVID-19 boosters for all US adults
0.864 0.622 Find similar Compare side-by-side
220902 ARSTECHNICA 2021-11-22:
COVID surge underway with daily cases already above 93K ahead of holiday
0.006 0.512 Find similar Compare side-by-side
220861 VENTUREBEAT 2021-11-20:
The one thing we’re NOT doing to mitigate the spread of COVID-19
0.364 Find similar Compare side-by-side
220488 ARSTECHNICA 2021-11-16:
Doctors are fighting back against fringe doctors pushing COVID misinformation
0.359 Find similar Compare side-by-side
220714 ZDNET 2021-11-19:
South Australia launches two digital tools for assessing travellers as part of opening border
0.285 Find similar Compare side-by-side
220441 VENTUREBEAT 2021-11-16:
Bluehole Publishes a Feature Story on Global Advocacy for Tobacco Harm Reduction Prior to WHO FCTC COP9
0.279 Find similar Compare side-by-side
220746 ZDNET 2021-11-18:
US attorneys-general kick off inquiry into Instagram's impact on teens
0.267 Find similar Compare side-by-side
220687 THEVERGE 2021-11-18:
Several states are investigating how Instagram keeps kids on the platform
0.266 Find similar Compare side-by-side
220747 VENTUREBEAT 2021-11-18:
Databricks integrates data tools with Partner Connect
0.256 Find similar Compare side-by-side
220936 ARSTECHNICA 2021-11-20:
Autism affects the microbiome, not the other way around
0.255 Find similar Compare side-by-side
220315 VENTUREBEAT 2021-11-17:
Groq accelerates COVID drug discovery at Argonne National Laboratory
0.252 Find similar Compare side-by-side
220353 VENTUREBEAT 2021-11-16:
Noteable expands analytics tools for programming with new $21M
0.251 Find similar Compare side-by-side
220646 VENTUREBEAT 2021-11-19:
Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors
0.249 Find similar Compare side-by-side
220787 ZDNET 2021-11-18:
Grab finds sweet spot of data lake and data warehouse in its centralised data platform
0.246 Find similar Compare side-by-side
220365 VENTUREBEAT 2021-11-16:
People Data Labs, which offers data as a service via APIs, raises $45M
0.245 Find similar Compare side-by-side
220342 VENTUREBEAT 2021-11-16:
MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round
0.231 Find similar Compare side-by-side
220432 VENTUREBEAT 2021-11-16:
Data management platform Bigeye unveils rapid dataset validation tool
0.231 Find similar Compare side-by-side
220729 ARSTECHNICA 2021-11-19:
At least 25 poisoned, 1 dead from “Real Alkalized Water,” CDC report reveals
0.228 Find similar Compare side-by-side
220450 VENTUREBEAT 2021-11-17:
Report: Flawed data management leads to lost revenue for most companies
0.217 Find similar Compare side-by-side
220559 VENTUREBEAT 2021-11-17:
Hightouch, which syncs data from warehouse to cloud apps, raises $40M
0.215 Find similar Compare side-by-side
221040 ZDNET 2021-11-22:
NextDC takes one-fifth stake in AUCloud during $35m capital raising
0.215 Find similar Compare side-by-side
220732 TECHREPUBLIC 2021-11-18:
Top 5 things to know about data intelligence
0.213 Find similar Compare side-by-side


ID: 220921


Date: 2021-11-19

Adults nationwide eligible for boosters this weekend as CDC gives sign-off

CDC advisers voted unanimously to expand booster eligibility. The Centers for Disease Control and Prevention has now signed off on offering booster doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines to all adults, allowing expanded boosting to begin nationwide this weekend. "Based on the compelling evidence, all adults over 18 should now have equitable access to a COVID-19 booster dose, CDC director Dr. Rochelle Walensky said in a statement this evening. Earlier today, the Food and Drug Administration authorized use of the boosters in all adults, and a committee of independent advisers for the CDC voted unanimously in favor of recommending boosters for all adults. Specifically, the committee voted unanimously (11-0) that people age 50 and over should get a booster six months after their second dose and that people age 18 and over may get a booster after their second dose. The committee came to the unanimous decisions after reviewing extensive safety data and clinical data showing that the third shots significantly elevated antibody levels. Booster shots have demonstrated the ability to safely increase peoples protection against infection and severe outcomes and are an important public health tool to strengthen our defenses against the virus as we enter the winter holidays, Dr. Walensky added in her statement. But safety and efficacy of the booster doses were not the only factors that convinced the advisers. They were also swayed by concerns of rising cases amid the winter holidays, as well as clear evidence that the current guidance on boosters is creating a barrier to extra protection. The committee heard recent survey data indicating that 40 percent of adults are unsure of whether they're currently eligible for a booster dose or not. Prior to today, boosters were only recommended for certain groups, creating confusion. Now, the guidance is simply that anyone age 18 and up who is fully vaccinated with any of the COVID-19 vaccines can get any of the vaccines as a booster. Though the Biden administration's months-long push for boosters for all adults has generated tension among experts and regulators, opposition to widespread boosting has faded recently. Many applauded today's decision, including Dr. Gerald Harmon, president of the American Medical Association. "We believe the FDAs authorization and the ACIP's recommendations in support of booster doses for all adults will help provide continued protection against COVID-19 as we head into the winter months," Dr. Harmon said in a statement. "Data presented today showed that adverse events following mRNA booster doses are similar to or lower than those seen after the primary vaccine series. The scientific evidence is clear that the vaccines against COVID-19 are safe and remain effective."